STAT1 and STAT3 activation during the course of experimental arthritis.

被引：0
|
作者：
de Hooge, ASK
van de Loo, FAJ
Kolbe, T
Mueller, M
Levy, DE
Bennink, M
Arntzl, OJ
van den Berg, WB
机构：
[1] UMC Nijmegen, Rheumatol Res Lab, Nijmegen, Netherlands
[2] Inst Agrobiotechnol, Tulln, Austria
[3] Inst Genet & Anim Breeding, Vienna, Austria
[4] NYU, Sch Med, Dept Pathol, New York, NY USA
[5] NYU, Sch Med, Kaplan Canc Ctr, New York, NY USA
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [21] STAT SIGNALING IN MALIGNANT MESOTHELIOMA: IS DEREGULATION OF STAT1 AND STAT3 CAUSED BY MICRORNAS?
    Arzt, Lisa
    Kothmaier, Hannelore
    Quehenberger, Franz
    Halbwedl, Iris
    Popper, Helmut H.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S709 - S709
  • [22] STAT1 and STAT3 mutations: important lessons for clinical immunologists
    Olbrich, Peter
    Freeman, Alexandra F.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (12) : 1029 - 1041
  • [23] EGFR dependent expression of STAT3 (but not STAT1) in breast cancer
    Berclaz, G
    Altermatt, HJ
    Rohrbach, V
    Siragusa, A
    Dreher, E
    Smith, PD
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (06) : 1155 - 1160
  • [24] STAT1/STAT3 Gain of Function and Mechanisms of Immune Dysregulation
    Kiykim, Ayca
    TURKISH JOURNAL OF IMMUNOLOGY, 2024, 12 : 47 - 52
  • [25] Implication of STAT1 and STAT3 transcription factors in the response to superantigens
    Plaza, R
    Vidal, S
    Rodriguez-Sanchez, JL
    Juarez, C
    CYTOKINE, 2004, 25 (01) : 1 - 10
  • [26] A20 CONTROLS ACTIVATION OF STAT1, BUT HAS NO EFFECT ON STAT3: IMPLICATIONS FOR DEVELOPMENT OF ENTHESITIS
    De Wilde, K.
    Martens, A.
    Coudenys, J.
    Debusschere, K.
    Verheugen, E.
    Windels, F.
    Beyaert, R.
    van Loo, G.
    Elewaut, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A5 - A5
  • [27] The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth
    Nivarthi, Harini
    Gordziel, Claire
    Themanns, Madeleine
    Kramer, Nina
    Eberl, Markus
    Rabe, Bjoern
    Schlederer, Michaela
    Rose-John, Stefan
    Knoesel, Thomas
    Kenner, Lukas
    Freund, Patricia
    Aberger, Fritz
    Han, Xiaonan
    Kralovics, Robert
    Dolznig, Helmut
    Jennek, Susanne
    Friedrich, Karlheinz
    Moriggl, Richard
    ONCOTARGET, 2016, 7 (32) : 51096 - 51106
  • [28] CTFH CELLS AS DISCRIMINATOR BETWEEN PATIENTS WITH STAT1 AND STAT3 MUTATIONS
    Moens, Leen
    Schaballie, Heidi
    Frans, Glynis
    Bosch, Barbara
    Schrijvers, Rik
    Corveleyn, Anniek
    Bossuyt, Xavier
    Meyts, Isabelle
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 259 - 259
  • [29] Measurement of STAT1 and STAT3 phosphorylation by Flow Cytometry and clinical indications
    Bitar, M.
    Boldt, A.
    Binder, S.
    Borte, M.
    Kentouche, K.
    Borte, S.
    Sack, U.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 178 - 178
  • [30] Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma
    Gordziel, C.
    Bratsch, J.
    Moriggl, R.
    Knoesel, T.
    Friedrich, K.
    BRITISH JOURNAL OF CANCER, 2013, 109 (01) : 138 - 146
12345